Back to Search Start Over

PD-0970 Biodistribution Data of ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr- Durvalumab.

Authors :
Hegi-Johnson, F.
Rudd, S.
Roselt, P.
Wichmann, C.
Callahan, J.
Akhurst, T.
Jackson, P.
Hicks, R.
Scott, A.
Donnelly, P.
John, T.
Hanna, G.
MacManus, M.
Source :
Radiotherapy & Oncology. 2023 Supplement 1, Vol. 182, pS817-S818. 2p.
Publication Year :
2023

Subjects

Subjects :
*PROGRAMMED death-ligand 1

Details

Language :
English
ISSN :
01678140
Volume :
182
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
166738058
Full Text :
https://doi.org/10.1016/S0167-8140(23)09043-6